Volume 18, Number 8—August 2012
Letter
blaNDM-1–positive Klebsiella pneumoniae from Environment, Vietnam
Table
Antimicrobial drug | MIC, mg/L |
|
---|---|---|
Site X | Site Y | |
Piperacillin/tazobactam | 64–>256 | 64–>256 |
Cefotaxime | 48–>256 | 96–128 |
Ceftazidime | >256 | >256 |
Ceftriaxone | 96–>256 | 128–>256 |
Meropenem | 8–>32 | 12–>32 |
Doripenem | 4–>32 | 8–>32 |
Imipenem | 6–>32 | >32 |
Fosfomycin | 3–8 | 8 |
Gentamicin | >1,024 | >1,024 |
Tobramycin | 384–>1,024 | 256–384 |
Ciprofloxacin | 0.064–1.5 | 0.064 |
Colistin | 0.19–2 | 0.125–0.38 |
Tgecycline | 1.5–3 | 0.5–1.5 |
*MICs were interpreted by using Clinical and Laboratory Standards Institute guidelines (www.clsi.org).
Page created: July 18, 2012
Page updated: July 18, 2012
Page reviewed: July 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.